Sedative and other effects of xylazine given intravenously to horses.
D000814:Aniline Compounds / Q000008:administration & dosage / Q000037:antagonists & inhibitors / Q000494:pharmacology; D000818:Animals; D001285:Atropine / Q000008:administration & dosage / Q000494:pharmacology; D001794:Blood Pressure / Q000187:drug effects; D001831:Body Temperature / Q000187:drug effects; D002245:Carbon Dioxide / Q000097:blood; D002302:Cardiac Output / Q000187:drug effects; D004562:Electrocardiography; D006339:Heart Rate / Q000187:drug effects; D006736:Horses; D006993:Hypnotics and Sedatives / Q000008:administration & dosage / Q000037:antagonists & inhibitors; D007275:Injections, Intravenous; D010100:Oxygen / Q000097:blood; D012119:Respiration / Q000187:drug effects; D013843:Thiazines / Q000008:administration & dosage / Q000037:antagonists & inhibitors / Q000494:pharmacology*; D014992:Xylenes / Q000008:administration & dosage / Q000037:antagonists & inhibitors / Q000494:pharmacology
D000814:Aniline Compounds; D006993:Hypnotics and Sedatives; D013843:Thiazines; D014992:Xylenes; D002245:Carbon Dioxide; D001285:Atropine; D010100:Oxygen